CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Stifel Nicolaus Healthcare Conference on Thursday, September 6, 2012 at 8:00 a.m. ET at the Four Seasons Hotel in Boston.
